June 2026 update: FDA issues 25 more warning letters to telehealth companies During the week of June 15, 2026 - days before this article was published - the FDA issued 25 additional warning letters to telehealth companies over false or misleading promotional claims about compounded GLP-1 products
Non-GMO and Organic Sourcing: Minimizing exposure to pesticides and genetically modified organisms is a priority for many expecting mothers
Before the infusion begins, a brief health screening confirms candidacy, reviews current medications and any contraindications, and identifies customization preferences such as additional wellness boosters or adjusted dosages
Liu L, Li X, Chen Y, Gao J, Jiang Y, Ye Y, et al
Medication and Side Effect Monitoring Keep track of medication usage and side effects associated with Ozempic, Wegovy, Mounjaro, and other GLP-1 options
Cycle duration and desensitization The pituitary gland can develop reduced sensitivity to repeated GHRP-6 stimulation over time